Development Level

Tbio 6 | 11,445
Tclin 3 | 613
Tchem 2 | 1,598
Tdark 1 | 6,588

IMPC Phenotype

abnormal retina morphology 1 | 71
cataract 1 | 92
increased anti-nuclear antigen... 1 | 19
preweaning lethality, complete... 1 | 979

Disease

Carcinoma 6 | 11,493
Congenital adrenal hyperplasia 6 | 73
ovarian cancer 6 | 8,520
Congenital adrenal insufficiency 4 | 7
Renal salt wasting 4 | 18
atypical teratoid / rhabdoid tumor 4 | 5,112
glioblastoma 4 | 5,792
malignant mesothelioma 4 | 3,232
Adenoma 3 | 167
Adrenal cortical adenoma 3 | 19
Autosomal recessive predisposition 3 | 1,442
Cancer 3 | 2,499
Cushing's syndrome 3 | 48
Endometrial Neoplasms 3 | 55
Hyperaldosteronism 3 | 35
Hypoaldosteronism 3 | 12
Kidney cancer 3 | 2,613
Mineralocorticoid insufficiency 3 | 12
adrenocortical carcinoma 3 | 1,428
adult high grade glioma 3 | 3,801
medulloblastoma, large-cell 3 | 6,241
Abnormal circulating renin 2 | 4
Adrenal hyperplasia 2 | 13
Adrenocorticotropic hormone excess 2 | 5
Adrenogenital Syndrome 2 | 6
Anovulation 2 | 21
Astrocytoma, Pilocytic 2 | 3,081
Blastomycosis 2 | 12
Candidiasis of mouth 2 | 5
Candidiasis of skin 2 | 6
Carcinoma in situ of adrenal cortex 2 | 2
Cholesterol monooxygenase (side-chain cleaving) deficiency 2 | 2
Chromoblastomycosis 2 | 10
Coccidioidomycosis 2 | 8
Conn's syndrome 2 | 22
Dehydration 2 | 40
Delayed bone age 2 | 136
Dexamethasone-suppresible primary hyperaldosteronism 2 | 2
Diagnostic Test for Secondary Adrenocortical Insufficiency 2 | 4
Disseminated candidiasis 2 | 4
Elevated plasma renin 2 | 9
Failure to gain weight 2 | 365
Familial primary hyperaldosteronism type 1 2 | 2
Glucocorticoid-remediable aldosteronism 2 | 2
Glucocorticoid-remediable familial primary aldosteronism 2 | 2
Histoplasmosis 2 | 13
Hyperaldosteronism, familial, type I 2 | 2
Hyperandrogenism 2 | 34
Hypercortisolism 2 | 8
Hyperkalemia 2 | 17
Hyperpigmentation 2 | 37
Hypertension 2 | 396
Hypertensive disease 2 | 292
Hypogonadism 2 | 173
Hypokalemia 2 | 52
Hyponatremia 2 | 25
Hypotension 2 | 82
Increase in blood pressure 2 | 119
Increased circulating ACTH level 2 | 8
Infertility 2 | 188
Kidney disease 2 | 430
Lipoid congenital adrenal hyperplasia 2 | 2
Low to undetectable plasma cortisol 2 | 12
Neonatal onset 2 | 21
Osteoporosis 2 | 363
Paracoccidioidomycosis 2 | 12
Pediatric failure to thrive 2 | 365
Pityriasis simplex 2 | 6
Pityriasis versicolor 2 | 19
Polycystic ovary syndrome 2 | 360
Proliferative diabetic retinopathy 2 | 4
Prostatic Neoplasms 2 | 495
Seborrheic dermatitis 2 | 31
Small testicle 2 | 75
Tinea corporis 2 | 25
Tinea cruris 2 | 12
Tinea pedis 2 | 29
Urogenital sinus anomaly 2 | 15
Vomiting 2 | 116
astrocytoma 2 | 1,146
cocaine use 2 | 11
group 4 medulloblastoma 2 | 1,855
juvenile dermatomyositis 2 | 1,187
osteosarcoma 2 | 7,950
posterior fossa group B ependymoma 2 | 416
ulcerative colitis 2 | 1,819
Abnormality of the urinary system 1 | 21
Anxiety disorder 1 | 23
Aortic root dilatation 1 | 11
Decreased fertility in females 1 | 20
Decreased plasma renin activity 1 | 9
Diabetic retinopathy 1 | 56
Fused labia minora 1 | 5
Generalized hyperpigmentation 1 | 22
Hepatitis 1 | 67
Hypoplasia of vagina 1 | 14
Hypotension, Orthostatic 1 | 18
Mitochondrial myopathy 1 | 26
Respiratory Distress Syndrome, Adult 1 | 40
Secondary malignant neoplasm of female breast 1 | 3

Tissue

Endocrine System 11 | 18,159
Digestive Tract 10 | 17,369
Male tissues 10 | 17,142
Respiratory system 10 | 16,393
Blood and immune system 9 | 16,909
Female tissues 9 | 17,400
Liver and Pancreas 9 | 16,750
Nervous System 9 | 16,725
Skin and soft tissues 9 | 17,230
Urinary Tract 9 | 16,678
Cardiovascular System 8 | 15,192

Target Family

Non-IDG 8 | 12,091
Enzyme 4 | 4,145

GO Process

C21-steroid hormone biosynthet... 12 | 12
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Ferredoxin-2, mitochondrial FDX2 Tdark Non-IDG -0.85150 6.83 4
Cytochrome P450 11B1, mitochondrial CYP11B1 Tclin Enzyme -2.66308 432.9 136
Steroidogenic acute regulatory protein, mitochondrial STAR Tbio Non-IDG -2.84388 738.4 199
Cytochrome P450 11B2, mitochondrial CYP11B2 Tchem Non-IDG -2.82678 695.9 162
Peripheral-type benzodiazepine receptor-associated protein 1 TSPOAP1 Tbio Non-IDG -0.53932 4.30 18
Adrenodoxin, mitochondrial FDX1 Tbio Non-IDG -2.81884 673.3 46
STARD3 N-terminal-like protein STARD3NL Tbio Non-IDG -0.59325 3.92 13
Aldose reductase AKR1B1 Tclin Enzyme -3.27314 1915.8 350
StAR-related lipid transfer protein 3 STARD3 Tbio Non-IDG -1.61721 39.4 37
Translocator protein TSPO Tchem Non-IDG -3.08695 2284.2 212